Lewis Macdonald & David Stewart 21st June 2011

We are waiting on the governments response to the following questions:

S4W-00992 Lewis Macdonald: To ask the Scottish Executive what proportion of type 1 diabetes patients would be eligible for insulin pump therapy if a glycaemic control target of between 6.5% and 7.5% was set.

S4W-00993 Lewis Macdonald: To ask the Scottish Executive what its position is on NHS boards following Scottish Intercollegiate Guidelines Network (SIGN) Guideline 116, Management of Diabetes, in relation to the use of insulin pump therapy to achieve a glycaemic control target of between 6.5% and 7.5%.

S4W-00994 Lewis Macdonald: To ask the Scottish Executive what criteria NHS boards apply for patients with type 1 diabetes seeking insulin pump therapy.

S4W-00995 Lewis Macdonald: To ask the Scottish Executive how many patients in each NHS board area with type 1 diabetes began insulin pump therapy in (a) 2007, (b) 2008, (c) 2009 and (d) 2010 and have begun in 2011.

S4W-00996 Lewis Macdonald: To ask the Scottish Executive how many patients with type 1 diabetes in each NHS board area received replacement pumps for insulin pump therapy in (a) 2007, (b) 2008, (c) 2009 and (d) 2010 and have received them in 2011.

S4W-01000 David Stewart: To ask the Scottish Executive how many (a) adult and (b) child patients use insulin pumps, broken down by NHS board.

Question S4W-00994 – Lewis Macdonald ( North East Scotland ) (Scottish Labour ) (Date Lodged 17/06/2011 ) :

To ask the Scottish Executive what criteria NHS boards apply for patients with type 1 diabetes seeking insulin pump therapy.

Answered by Michael Matheson ( 14/07/2011 ):The Diabetes Action Plan, published in August 2010, makes it clear that we expect NHS boards to ensure that provision of insulin pump therapy reflects guidance as set out within NICE Technology Appraisal 151 and SIGN Guideline 116 on the management of diabetes.

 

Question S4W-00993 – Lewis Macdonald ( North East Scotland ) (Scottish Labour ) (Date Lodged 17/06/2011 ) :

To ask the Scottish Executive what its position is on NHS boards following Scottish Intercollegiate Guidelines Network (SIGN) Guideline 116, Management of Diabetes, in relation to the use of insulin pump therapy to achieve a glycaemic control target of between 6.5% and 7.5%.

Answered by Michael Matheson ( 14/07/2011 ):

The Diabetes Action Plan, published in August 2010, makes it clear that we expect NHS Boards to adhere to the guidance on insulin pump therapy set out in NICE Technology Appraisal TA15, and SIGN Guideline 116 on the management of diabetes.

This guidance indicates that glycaemic control is only one of a number criteria for determining patient’s suitability for insulin pump therapy.

Appendix 2 of the Diabetes Action Plan, published in August 2010, includes details of each NHS board’s planned investment over the next three to five years on pumps and the structured education associated with it, presenting a clear picture of proposed provision across the whole of Scotland. A summary table can be accessed at: www.scotland.gov.uk/Publications/2010/08/17095311.

NHS boards will find it helpful to assess their investment plans against clinical and resource impact report produced by SIGN to accompany Guideline 116.

Question S4W-00995 – Lewis Macdonald ( North East Scotland ) (Scottish Labour ) (Date Lodged 17/06/2011 ) :

To ask the Scottish Executive how many patients in each NHS board area with type 1 diabetes began insulin pump therapy in (a) 2007, (b) 2008, (c) 2009 and (d) 2010 and have begun in 2011.

Answered by Michael Matheson ( 14/07/2011 ):

Information on the percentage of people with type 1 diabetes on insulin pump therapy, in each NHS board, between 2007 and 2009 was provided in the answer to question S3W-21510 on 10 March 2009.

Data on insulin pump provision in each NHS board is included in both the 2009 and 2010 Diabetes Surveys.

This information is set out within the following table:

INSULIN PUMP PROVISION IN SCOTLAND 2009 – 2010 BROKEN DOWN BY NHS BOARD

NHS BOARD

TYPE 1 POPULATION 2009

NUMBER OF PUMPS 2009

PERCENTAGE

2009

TYPE 1 POPULATION 2010

NUMBER OF PUMPS 2010

PERCENTAGE 2010

Ayrshire & Arran

2,234

9

0.40%

2,238

18

0.80%

Borders

596

23

3.90%

601

29

4.80%

Dumfries & Galloway

871

12

1.40%

888

20

2.30%

Fife

1,896

83

4.40%

1,911

113

5.90%

Forth Valley

1,526

24

1.60%

1,568

40

2.60%

Grampian

2,976

59

2.00%

3,045

63

2.10%

Greater Glasgow & Clyde

5,923

56

0.90%

6,115

67

1.10%

Highland

1,688

19

1.10%

1,706

18

1.10%

Lanarkshire

3,454

38

1.10%

3,480

45

1.30%

Lothian

4,019

142

3.50%

4,109

173

4.20%

Orkney

118

3

2.50%

116

3

2.60%

Shetland

114

2

1.80%

119

2

1.70%

Tayside

1,771

82

4.60%

1,837

104

5.70%

Western Isles

181

1

0.60%

177

1

0.60%

Scotland

27,367

553

2.00%

27,910

696

2.50%

Data on insulin pump provision in each NHS board for 2011 is not yet centrally held but will be included in the Diabetes Survey 2011 when it is published next year.

Question S4W-00992 – Lewis Macdonald ( North East Scotland ) (Scottish Labour ) (Date Lodged 17/06/2011 ) :

To ask the Scottish Executive what proportion of type 1 diabetes patients would be eligible for insulin pump therapy if a glycaemic control target of between 6.5% and 7.5% was set.

Answered by Michael Matheson ( 14/07/2011 ):

This information is not centrally held.

Guidance on insulin pump therapy is set out within:

NICE Technology Appraisal TA151 which was endorsed by NHS Quality Improvement Scotland (now Healthcare Improvement Scotland) in July 2008; and,

SIGN Guideline 116 on the management of diabetes, published in March 2010.

The guidance is clear that glycaemic control is only one of a number criteria for determining patient suitability for insulin pump therapy.

Question S4W-00996 – Lewis Macdonald ( North East Scotland ) (Scottish Labour ) (Date Lodged 17/06/2011 ) :

To ask the Scottish Executive how many patients with type 1 diabetes in each NHS board area received replacement pumps for insulin pump therapy in (a) 2007, (b) 2008, (c) 2009 and (d) 2010 and have received them in 2011.

Answered by Michael Matheson ( 14/07/2011 ):

This information is not centrally held.

We expect that people who require a replacement pump to receive it in good time to ensure that their optimal clinical care is maintained.